15-100885292-A-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_000693.4(ALDH1A3):āc.125A>Cā(p.Glu42Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000105 in 1,613,772 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_000693.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ALDH1A3 | NM_000693.4 | c.125A>C | p.Glu42Ala | missense_variant | 2/13 | ENST00000329841.10 | NP_000684.2 | |
ALDH1A3 | NM_001293815.2 | c.125A>C | p.Glu42Ala | missense_variant | 2/10 | NP_001280744.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ALDH1A3 | ENST00000329841.10 | c.125A>C | p.Glu42Ala | missense_variant | 2/13 | 1 | NM_000693.4 | ENSP00000332256 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152262Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000398 AC: 10AN: 251458Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135908
GnomAD4 exome AF: 0.00000821 AC: 12AN: 1461392Hom.: 0 Cov.: 30 AF XY: 0.00000550 AC XY: 4AN XY: 727048
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152380Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74520
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 19, 2024 | The c.125A>C (p.E42A) alteration is located in exon 2 (coding exon 2) of the ALDH1A3 gene. This alteration results from a A to C substitution at nucleotide position 125, causing the glutamic acid (E) at amino acid position 42 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at